Grant Napier
About Grant Napier
Grant Napier is a Senior Product Manager at Nautilus Biotechnology, where he has worked since 2021. He has extensive experience in product management and development, particularly in the biotechnology and diagnostics sectors, with a history of roles at Roche and other organizations.
Work at Nautilus Biotechnology
Grant Napier serves as a Senior Product Manager at Nautilus Biotechnology, a position he has held since 2021. He is based in San Carlos, California. In this role, he focuses on product management strategies that align with the company's goals in biotechnology.
Previous Experience at Roche
Before joining Nautilus Biotechnology, Grant Napier worked at Roche in various capacities. He was the Senior International Product Manager for Sequencing Systems from 2019 to 2020. Prior to that, he served as the Project Lead for Sequencing Platforms from 2015 to 2017 and as the Senior Project Manager for Nanopore Sequencing Platforms from 2017 to 2019. His roles at Roche involved overseeing product development and project management in the sequencing domain.
Career at Wits Health Consortium
Grant Napier worked as a Business Development Manager at Wits Health Consortium from 2001 to 2006. In this position, he contributed to the organization's growth by identifying and pursuing new business opportunities in the health sector.
Experience at GALVmed
From 2011 to 2014, Grant Napier held the position of Programme Manager for Animal African Trypanosomosis at GALVmed in Edinburgh, United Kingdom. His role involved managing programs aimed at addressing health challenges in livestock.
Early Career at Roche Diagnostics and Boehringer Mannheim
Grant Napier began his career in the biotechnology field at Roche Diagnostics, where he worked as a Product Specialist in Molecular Diagnostics for four months in 1998, followed by a two-year tenure as Product Manager from 1999 to 2001. He also worked as a Sales Representative for Biochemicals at Boehringer Mannheim from 1996 to 1998 in Johannesburg, South Africa.